Drugs / CBMNC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03855202 | Feb → Aug 2019 | — | yangjie | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBMNC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03855202 ↗ |
| Modality | Cell therapy | “autologuous umbilical cord blood mononuclear cells” NCT03855202 ↗ |